Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 694-697

  Bickerstaff, M C M ^a   Botto, M ^a   Hutchinson, W L ^a   Herbert, J ^a   Tennent, G A ^a   Bybee, A ^a   Mitchell, D A ^a   Cook, H T ^a   Butler, P J G ^b   Walport, M J ^a   Pepys, M B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE H1; SERUM AMYLOID P;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CELL DEATH; CHROMATIN; CONTROLLED STUDY; DNA BINDING; EXTRACELLULAR FLUID; FEMALE; HISTOLOGY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOIMMUNITY; CARRIER PROTEINS; CHROMATIN; COMPLEMENT C1Q; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNIZATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NUCLEAR PROTEINS;

ANIMALIA;

EID: 0033059667     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9544     Document Type: Article

References (28)

1. Pepys, M.B. et al. Amyloid P component. A critical review. Amyloid: Int. J. Exp. Clin. Invest. 4, 274-295 (1997).
2. Pepys, M.B. & Butler, P.J.G. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148, 308-313 (1987).
3. Pepys, M.B., Booth, S.E., Tennent, G.A., Butler, P.J.G. & Williams, D.G. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin. Exp. Immunol. 97, 152-157 (1994).
4. Butler, P.J.G., Tennent, G.A. & Pepys, M.B. Pentraxin-chromatin interactions. Serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J. Exp. Med. 172, 13-18 (1990).
5. Hintner, H. et al. Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro. J. Invest. Dermatol. 91, 22-28 (1988).
6. Casciola-Rosen, L.A., Anhalt, C. & Rosen, A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330 (1994).
7. Breathnach, S.M. et al. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 170, 1433-1438 (1989).
8. Botto, M. et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Medicine 3, 855-859 (1997).
9. Pepys, M.B. & Baltz, M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34, 141-212 (1983).
10. Tennent, G.A., Lovat, L.B. & Pepys, M.B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA 92, 4299-4303 (1995).
11. Botto, M. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56-59 (1998).
12. Hutchinson, W.L., Noble, G.E., Hawkins, P.N. & Pepys, M.B. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. I. Clin. Invest. 94, 1390-1396 (1994).
13. Burlingame, R.W., Volzer, MA, Harris, J & Du Clos, T.W. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J. Immunol. 156, 4783-4788 (1996).
14. Gauthier, V.J., Tyler, L.N. & Mannik, M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J. Immunol. 156, 1151-1156 (1996).
15. Pepys, M.B., Lanham, J.G. & de Beer, F.C. in Clinics in the Rheumatic Diseases (eds. Hughes, G.R.V.) 91-103 (W.B. Saunders, Eastbourne, UK, 1982).
16. Emsley, J. et al. Structure of pentameric human serum amyloid P component. Nature 367, 338-345 (1994).
17. Thompson, D., Pepys, M.B. & Wood, S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7, 169-177 (1999).
18. Pepys, M.B., Baltz, M., Gomer, K., Davies, A.J.S. & Doenhoff, M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278, 259-261 (1979).
19. 1 and MRL/1 mice. Contrasting patterns resembling those in human systemic lupus erythematosus and rheumatoid arthritis respectively. J. Exp. Med. 156, 1268-1273 (1982).
20. Du Clos, T.W. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143, 2553-2559 (1989).
21. Reichlin, M. et al. Lupus autoantibodies to native DNA cross-react with the A and D snRNP polypeptides. J. Clin. Invest. 93, 443-449 (1994).
22. Nakayama, S., Du Clos, T.W., Gewurz, H. & Mold, C. Inhibition of antibody responses to phosphocholine by C-reactive protein. J. Immunol. 132, 1336-1340 (1984).
23. Hughes, G.R.V. Hughes syndrome: the antiphospholipid syndrome. J. R. Coll. Physicians Lond. 32, 260-264 (1998).
24. Molden, D.P., Nakamura, R.M. & Tan, E.M. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am. J. Clin. Pathol. 82, 57-66 (1984).
25. Isenberg, D.A. et al. Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann. Rheum. Dis. 46, 448-456 (1987).
26. Burlingame, R.W. & Rubin, R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods 134, 187-199 (1990).
27. Pepys, M.B., Dash, A.C., Fielder, A.H.L. & Mirjah, D.D. Isolation and study of murine C3. Immunology 33, 491-499 (1977).
28. Mather, S.J. & Ward, B.C. High efficiency iodination of monoclonal antibodies for radiotherapy. J. Nucl. Med. 28, 1034-1036 (1987).